Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi MSCI Europe Growth UCITS ETF Acc

CG9 · LU1681042435 · class UCITS ETF Acc · EUR · domicile Luxembourg
Equity · EuropeSFDR art. 6
Index tracked: MSCI Europe Growth Daily EUR TR Net EUR
TER
0.35%+ trans. 0.10%
Fund size
177 m EUR
Tracking difference
−0.26%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical
Income
Accumulating
Launch 30 Jan 2018 · costs from the KID as of 2 Sept 2026 · 222 securities held · 7 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The objective of this Sub-Fund is to track the performance of MSCI Europe Growth Index, and to minimize the tracking error between the net asset value of the Sub-Fund and the performance of the Index. The anticipated level of the tracking error, under normal market conditions, is indicated in the prospectus of the Sub-Fund. The Index is a Net Total Return Index : dividends net of tax paid by the index constituents are included in the Index return. MSCI Europe Growth Index is an equity index representative of leading securities traded in the markets of…

Performance since series start (in euro) — base 100

31 Jan 20188 Sept 2026 · dividends reinvested where declared by the issuer
201920212023202519388188
High 193 (6 Jul 2026) · low 88 (3 Jan 2019) · last 188. Past performance is not indicative of future results.

Returns in euro

1 year+14.1%
3 years+30.6%
5 years+22.7%
10 yearsseries too young
Since series start+88.2%

Risk · 1 / 3 / 5 years

Volatility (ann.)15.05%14.32%15.69%
Max drawdown−10.89%−18.48%−24.89%
Sharpe0.750.470.19
Sortino1.170.670.27
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · CG9 · LU16810424351
RebalixCG9 · LU1681042435 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+8.68%+8.89%−0.21%
2024+5.74%+5.99%−0.25%
2023+15.82%+16.14%−0.32%
2022−17.94%−17.66%−0.28%
2021+27.57%+28.05%−0.48%

Holdings

Portfolio as declared by the issuer · 1 Sept 2026 · 222 securities · top-10 weight = 31.2%
Top holdingsWeight
ASML HOLDING NV9.2%
ASTRAZENECA GBP3.5%
SAP SE / XETRA3.1%
SCHNEIDER ELECT SE2.6%
UBS GROUP AG2.4%
ROLLS-ROYCE HOLDINGS PLC2.4%
ABB LTD-REG2.1%
NOVO NORDISK A/S-B2.1%
AIRBUS SE PARIS1.9%
SAFRAN SA1.9%
Countries (% of fund)
United Kingdom19.5%France14.7%Switzerland14.6%Germany13.9%Netherlands12.8%
Sectors (% of fund)
Industrials31.2%Information Technology16.5%Health Care16.2%Financials9.8%Consumer Discretionary9.0%

Listing venues

ESMA register (FIRDS) and official exchange lists
X135 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange
CG9 · Euronext Paris
+ 18 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/LU1681042435/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/LU1681042435/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/LU1681042435/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/LU1681042435
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · CG9 · LU16810424352